CoChat

Neuronal Loss of the Glutamate Transporter GLT-1 Promotes Excitotoxic Injury in the Hippocampus

Open access
Rimmele, Theresa S., Li, Shaomin, Andersen, Jens Velde, Westi, Emil W., Rotenberg, Alexander, Wang, Jianlin, Aldana, Blanca Irene, Selkoe, Dennis J., Aoki, Chiye J., Dulla, Chris G., Rosenberg, Paul Allen · 2021 · Frontiers in Cellular Neuroscience
Cited by 41

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

GLT-1, the major glutamate transporter in the mammalian central nervous system, is expressed in presynaptic terminals that use glutamate as a neurotransmitter, in addition to astrocytes. It is widely assumed that glutamate homeostasis is regulated primarily by glutamate transporters expressed in astrocytes, leaving the function of GLT-1 in neurons relatively unexplored. We generated conditional GLT-1 knockout (KO) mouse lines to understand the cell-specific functions of GLT-1. We found that stimulus-evoked field extracellular postsynaptic potentials (fEPSPs) recorded in the CA1 region of the hippocampus were normal in the astrocytic GLT-1 KO but were reduced and often absent in the neuronal GLT-1 KO at 40 weeks. The failure of fEPSP generation in the neuronal GLT-1 KO was also observed in slices from 20 weeks old mice but not consistently from 10 weeks old mice. Using an extracellular FRET-based glutamate sensor, we found no difference in stimulus-evoked glutamate accumulation in the neuronal GLT-1 KO, suggesting a postsynaptic cause of the transmission failure. We hypothesized that excitotoxicity underlies the failure of functional recovery of slices from the neuronal GLT-1 KO. Consistent with this hypothesis, the non-competitive NMDA receptor antagonist MK801, when present in the ACSF during the recovery period following cutting of slices, promoted full restoration of fEPSP generation. The inclusion of an enzymatic glutamate scavenging system in the ACSF conferred partial protection. Excitotoxicity might be due to excess release or accumulation of excitatory amino acids, or to metabolic perturbation resulting in increased vulnerability to NMDA receptor activation. Previous studies have demonstrated a defect in the utilization of glutamate by synaptic mitochondria and aspartate production in the synGLT-1 KO in vivo, and we found evidence for similar metabolic perturbations in the slice preparation. In addition, mitochondrial cristae density was higher in synaptic mitochondria in the CA1 region in 20–25 weeks old synGLT-1 KO mice in the CA1 region, suggesting compensation for loss of axon terminal GLT-1 by increased mitochondrial efficiency. These data suggest that GLT-1 expressed in presynaptic terminals serves an important role in the regulation of vulnerability to excitotoxicity, and this regulation may be related to the metabolic role of GLT-1 expressed in glutamatergic axon terminals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fncel.2021.788262

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 123

  1. Aarts, 2014, A solution to dependency: using multilevel analysis to accommodate nested data, Nat. Neurosci., 17, 491, 10.1038/nn.3648 · DOI · Paper page
  2. Aida, 2015, Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in mice, Neuropsychopharmacology, 40, 1569, 10.1038/npp.2015.26 · DOI · Paper page
  3. Albuquerque, 2013, Kynurenic acid as an antagonist of alpha7 nicotinic acetylcholine receptors in the brain: facts and challenges, Biochem. Pharmacol., 85, 1027, 10.1016/j.bcp.2012.12.014 · DOI · Paper page
  4. Andersen, Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration, Neuropharmacology, 196, 108719, 10.1016/j.neuropharm.2021.108719 · DOI · Paper page
  5. Andersen, Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer’s disease, Neurobiol. Dis., 148, 105198, 10.1016/j.nbd.2020.105198 · DOI · Paper page
  6. Andersen, Impaired hippocampal glutamate and glutamine metabolism in the db/db mouse model of type 2 diabetes mellitus, Neural Plasticity, 2017, 2107084, 10.1155/2017/2107084 · DOI · Paper page
  7. Andersen, Alterations in cerebral cortical glucose and glutamine metabolism precedes amyloid plaques in the APPswe/PSEN1dE9 mouse model of Alzheimer’s disease, Neurochem. Res., 42, 1589, 10.1007/s11064-016-2070-2 · DOI
  8. Bennett, 1972, Amino acid neurotransmitter candidates: sodium-dependent high-affinity uptake by unique synaptosomal fractions, Science, 178, 997, 10.1126/science.178.4064.997 · doi:10.1126/science.178.4064.997
  9. Berger, 2005, Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization, J. Comp. Neurol., 492, 78, 10.1002/cne.20737 · DOI · Paper page
  10. Berger, 1998, Comparative analysis of glutamate transporter expression in rat brain using differential double in situ hybridization, Anat. Embryol. (Berl), 198, 13, 10.1007/s004290050161 · DOI
  11. Bergles, 1999, Clearance of glutamate inside the synapse and beyond, Curr. Opin. Neurobiol., 9, 293, 10.1016/s0959-4388(99)80043-9 · DOI · Paper page
  12. Bezzi, 1999, Astrocytes as active participants of glutamatergic function and regulators of its homeostasis, Adv. Exp. Med. Biol., 468, 69, 10.1007/978-1-4615-4685-6_6 · DOI
  13. Blitzblau, 1996, The glutamate transport inhibitor L- trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures, Eur. J. Neurosci., 8, 1840, 10.1111/j.1460-9568.1996.tb01328.x · DOI
  14. Boisgontier, 2016, The anova to mixed model transition, Neurosci. Biobehav. Rev., 68, 1004, 10.1016/j.neubiorev.2016.05.034 · DOI · Paper page
  15. Buskila, 2020, Extending the life span of acute neuronal tissue for imaging and electrophysiological studies, 235, 10.1007/978-1-4939-9944-6_10 · DOI
  16. Buskila, 2014, Extending the viability of acute brain slices, Sci. Rep., 4, 5309, 10.1038/srep05309 · DOI
  17. Casper, 2007, Characterization of astrocyte-specific conditional knockouts, Genesis, 45, 292, 10.1002/dvg.20287 · DOI · Paper page
  18. Chen, 1997, Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism, J. Physiol., 499, 27, 10.1113/jphysiol.1997.sp021909 · DOI · Paper page
  19. Chen, 2004, The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons, J. Neurosci., 24, 1136, 10.1523/JNEUROSCI.1586-03.2004 · DOI · Paper page
  20. Choi, 1985, Glutamate neurotoxicity in cortical cell culture is calcium dependent, Neurosci. Lett., 58, 293, 10.1016/0304-3940(85)90069-2 · DOI · Paper page
  21. Choi, 1988, Glutamate neurotoxicity and diseases of the nervous system, Neuron, 1, 623, 10.1016/0896-6273(88)90162-6 · DOI · Paper page
  22. Choi, 2020, Excitotoxicity: still hammering the ischemic brain in 2020, Front. Neurosci., 14, 579953, 10.3389/fnins.2020.579953 · DOI · Paper page
  23. Choi, 1987, Glutamate neurotoxicity in cortical cell culture, J. Neurosci., 7, 357, 10.1523/JNEUROSCI.07-02-00357.1987 · DOI · Paper page
  24. Churchwell, 1996, NMDA receptor activation inhibits neuronal volume regulation after swelling induced by veratridine-stimulated Na+ influx in rat cortical cultures, J. Neurosci., 16, 7447, 10.1523/JNEUROSCI.16-23-07447.1996 · DOI · Paper page
  25. Collado, 2009, Post-translational regulation of an Aplysia glutamate transporter during long-term facilitation, J. Neurochem., 108, 176, 10.1111/j.1471-4159.2008.05757.x · doi:10.1111/j.1471-4159.2008.05757.x
  26. Collado, 2007, in vivo regulation of an Aplysia glutamate transporter, ApGT1, during long-term memory formation, J. Neurochem., 100, 1315, 10.1111/j.1471-4159.2006.04298.x · DOI
  27. Danbolt, 2001, Glutamate uptake, Prog. Neurobiol., 65, 1, 10.1016/s0301-0082(00)00067-8 · DOI · Paper page
  28. Davies, 1981, 2-amino-5-phosphonovalerate (2-APV)., a potent and selective antagonist of amino acid-induced and synaptic excitation, Neurosci. Lett., 21, 77, 10.1016/0304-3940(81)90061-6 · DOI · Paper page
  29. Dittman, 2000, Interplay between facilitation, depression and residual calcium at three presynaptic terminals, J. Neurosci., 20, 1374, 10.1523/jneurosci.20-04-01374.2000 · DOI · Paper page
  30. Doetschman, 2009, Influence of genetic background on genetically engineered mouse phenotypes, Methods Mol. Biol., 530, 423, 10.1007/978-1-59745-471-1_23 · DOI · Paper page
  31. Dulla, 2008, Imaging of glutamate in brain slices using FRET sensors, J. Neurosci. Methods, 168, 306, 10.1016/j.jneumeth.2007.10.017 · DOI
  32. Espanol, 1994, Modulation of edema by dizocilpine, kynurenate and NBQX in respiring brain slices after exposure to glutamate, Acta Neurochir. Suppl. (Wien)., 60, 58, 10.1007/978-3-7091-9334-1_15 · doi:10.1007/978-3-7091-9334-1_15
  33. Feher, 2019, Structural evaluation and electrophysiological effects of some kynurenic acid analogs, Molecules, 24, 3502, 10.3390/molecules24193502 · DOI
  34. Feig, 1990, N-methyl-D-aspartate receptor activation and Ca2+ account for poor pyramidal cell structure in hippocampal slices, J. Neurochem., 55, 473, 10.1111/j.1471-4159.1990.tb04160.x · DOI
  35. Fiala, 2003, Timing of neuronal and glial ultrastructure disruption during brain slice preparation and recovery in vitro, J. Comp. Neurol., 465, 90, 10.1002/cne.10825 · DOI · Paper page
  36. Fischer, 2018, Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine, Psychopharmacology (Berl)., 235, 1371, 10.1007/s00213-018-4848-1 · DOI
  37. Fischer, 2020, Glutamate homeostasis and dopamine signaling: implications for psychostimulant addiction behavior, Neurochem. Int., 144, 104896, 10.1016/j.neuint.2020.104896 · DOI
  38. Foster, 1984, Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid, Neurosci. Lett., 48, 273, 10.1016/0304-3940(84)90050-8 · DOI · Paper page
  39. Frenguelli, 2019, The purine salvage pathway and the restoration of cerebral ATP: implications for brain slice physiology and brain injury, Neurochem. Res., 44, 661, 10.1007/s11064-017-2386-6 · DOI
  40. Frenguelli, 2020, Purines: from diagnostic biomarkers to therapeutic agents in brain injury, Neurosci. Bull., 36, 1315, 10.1007/s12264-020-00529-z · DOI
  41. Ganat, 2006, Early postnatal astroglial cells produce multilineage precursors and neural stem cells in vivo, J. Neurosci., 26, 8609, 10.1523/JNEUROSCI.2532-06.2006 · DOI · Paper page
  42. Ganong, 1983, Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord, Brain Res., 273, 170, 10.1016/0006-8993(83)91108-3 · DOI · Paper page
  43. Genda, 2011, Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria, J. Neurosci., 31, 18275, 10.1523/JNEUROSCI.3305-11.2011 · DOI · Paper page
  44. Gomes, 2011, Essential amino acids and glutamine regulate induction of mitochondrial elongation during autophagy, Cell Cycle, 10, 2635, 10.4161/cc.10.16.17002 · DOI
  45. Gonzalez Esquivel, 2017, Kynurenine pathway metabolites and enzymes involved in redox reactions, Neuropharmacology, 112, 331, 10.1016/j.neuropharm.2016.03.013 · DOI
  46. Hall, 2018, The combination of ribose and adenine promotes adenosine release and attenuates the intensity and frequency of epileptiform activity in hippocampal slices: evidence for the rapid depletion of cellular ATP during electrographic seizures, J. Neurochem., 147, 178, 10.1111/jnc.14543 · DOI
  47. Hanson, 2019, Tonic activation of GluN2C/GluN2D-containing NMDA receptors by ambient glutamate facilitates cortical interneuron maturation, J. Neurosci., 39, 3611, 10.1523/JNEUROSCI.1392-18.2019 · DOI · Paper page
  48. Henneberry, Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons. An hypothesis for cell death in aging and disease, Ann. N Y Acad. Sci., 568, 225, 10.1111/j.1749-6632.1989.tb12512.x · DOI · Paper page
  49. Henneberry, Energy-related neurotoxicity at the NMDA receptor: a possible role in Alzheimer’s disease and related disorders, Prog. Clin. Biol. Res., 317, 143
  50. Honore, 1988, Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists, Science, 241, 701, 10.1126/science.2899909 · DOI · Paper page
  51. Hossmann, 2008, Cerebral ischemia: models, methods and outcomes, Neuropharmacology, 55, 257, 10.1016/j.neuropharm.2007.12.004 · DOI · Paper page
  52. Huang, 2018, Excitatory and inhibitory synapse reorganization immediately after critical sensory experience in a vocal learner, eLife, 7, e37571, 10.7554/eLife.37571 · DOI
  53. Inquimbert, 2012, Peripheral nerve injury produces a sustained shift in the balance between glutamate release and uptake in the dorsal horn of the spinal cord, Pain, 153, 2422, 10.1016/j.pain.2012.08.011 · DOI · Paper page
  54. Inquimbert, 2018, NMDA receptor activation underlies the loss of spinal dorsal horn neurons and the transition to persistent pain after peripheral nerve injury, Cell Rep., 23, 2678, 10.1016/j.celrep.2018.04.107 · DOI · Paper page
  55. Kass, 1989, The N-methyl-D-aspartate antagonists aminophosphonovaleric acid and MK-801 reduce anoxic damage to dentate granule and CA1 pyramidal cells in the rat hippocampal slice, Exp. Neurol., 103, 116, 10.1016/0014-4886(89)90072-1 · doi:10.1016/0014-4886(89)90072-1
  56. Katagiri, 2001, Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction, Eur. J. Neurosci., 14, 547, 10.1046/j.0953-816x.2001.01664.x · DOI · Paper page
  57. Kim, 2012, Decreased afferent excitability contributes to synaptic depression during high-frequency stimulation in hippocampal area CA1, J. Neurophysiol., 108, 1965, 10.1152/jn.00276.2011 · DOI
  58. Kirov, 1999, Slices have more synapses than perfusion-fixed hippocampus from both young and mature rats, J. Neurosci., 19, 2876, 10.1523/JNEUROSCI.19-08-02876.1999 · DOI · Paper page
  59. Koenig, 2019, Glycolytic inhibitor 2-deoxyglucose prevents cortical hyperexcitability after traumatic brain injury, JCI Insight, 5, e126506, 10.1172/jci.insight.126506 · DOI
  60. Krall, 2020, Synaptic zinc inhibition of NMDA receptors depends on the association of GluN2A with the zinc transporter ZnT1, Sci. Adv., 6, eabb1515, 10.1126/sciadv.abb1515 · DOI · Paper page
  61. Kurucu, 2021, Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer’s disease, Eur. J. Neurol., 10.1111/ene.15043 · DOI · Paper page
  62. Lau, 2017, alpha2delta-1 signaling drives cell death, synaptogenesis, circuit reorganization and gabapentin-mediated neuroprotection in a model of insult-induced cortical malformation, eNeuro, 4, ENEURO.0316, 10.1523/ENEURO.0316-17.2017 · DOI
  63. Lee, Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes, Toxicol. Sci., 110, 156, 10.1093/toxsci/kfp081 · DOI
  64. Lee, Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes, J. Neurochem., 110, 530, 10.1111/j.1471-4159.2009.06105.x · DOI · Paper page
  65. Leveille, 2017, Mitochondrial cristae density: a dynamic entity that is critical for energy production and metabolic power in skeletal muscle, J. Physiol., 595, 2779, 10.1113/JP274158 · DOI
  66. Levenson, Localization of glutamate and glutamate transporters in the sensory neurons of Aplysia, J. Comp. Neurol., 423, 121, 10.1002/1096-9861(20000717)423:1<121::aid-cne10>3.0.co;2-e · DOI
  67. Levenson, Long-term regulation of neuronal high-affinity glutamate and glutamine uptake in Aplysia, Proc. Natl. Acad. Sci. U S A, 97, 12858, 10.1073/pnas.220256497 · DOI · Paper page
  68. Levenson, 2002, Glutamate uptake in synaptic plasticity: from mollusc to mammal, Curr. Mol. Med., 2, 593, 10.2174/1566524023362069 · DOI
  69. Lewerenz, 2015, Chronic glutamate toxicity in neurodegenerative diseases-what is the evidence?, Front. Neurosci., 9, 469, 10.3389/fnins.2015.00469 · DOI · Paper page
  70. Li, 2009, Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake, Neuron, 62, 788, 10.1016/j.neuron.2009.05.012 · DOI · Paper page
  71. Lipton, 1994, Excitatory amino acids as a final common pathway for neurologic disorders, N. Engl. J. Med., 330, 613, 10.1056/NEJM199403033300907 · DOI · Paper page
  72. Logan, 1971, Unique high affinity system for glycine, glutamic and aspartic acids in central nervous tissue in the rat, Nature, 234, 297, 10.1038/234297b0 · DOI · Paper page
  73. McKay, 2013, Recovery of NMDA receptor currents from MK-801 blockade is accelerated by Mg2+ and memantine under conditions of agonist exposure, Neuropharmacology, 74, 119, 10.1016/j.neuropharm.2013.01.024 · DOI
  74. McNair, 2019, Deletion of neuronal GLT-1 in mice reveals its role in synaptic glutamate homeostasis and mitochondrial function, J. Neurosci., 39, 4847, 10.1523/JNEUROSCI.0894-18.2019 · DOI · Paper page
  75. McNair, 2020, Conditional knockout of GLT-1 in neurons leads to alterations in aspartate homeostasis and synaptic mitochondrial metabolism in striatum and hippocampus, Neurochem. Res., 45, 1420, 10.1007/s11064-020-03000-7 · DOI
  76. Meldrum, 1990, Excitatory amino acid neurotoxicity and neurodegenerative disease, Trends Pharmacol. Sci., 11, 379, 10.1016/0165-6147(90)90184-a · DOI · Paper page
  77. Mitra, 2012, An in vitro spinal cord slice preparation for recording from lumbar motoneurons of the adult mouse, J. Neurophysiol., 107, 728, 10.1152/jn.00558.2011 · DOI
  78. Mukhamedyarov, 2006, Paired-pulse facilitation of transmitter release at different levels of extracellular calcium concentration, Neurochem. Res., 31, 1055, 10.1007/s11064-006-9115-x · doi:10.1007/s11064-006-9115-x
  79. Nathan, 1990, GABAB receptors play a major role in paired-pulse facilitation in area CA1 of the rat hippocampus, Brain Res., 531, 55, 10.1016/0006-8993(90)90757-3 · DOI
  80. Nathan, 1991, Depression of the fast IPSP underlies paired-pulse facilitation in area CA1 of the rat hippocampus, J. Neurophysiol., 66, 1704, 10.1152/jn.1991.66.5.1704 · DOI
  81. Novelli, 1988, Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced, Brain Res., 451, 205, 10.1016/0006-8993(88)90765-2 · DOI · Paper page
  82. O’Brien, 1986, Modulation of embryonic chick motoneuron glutamate sensitivity by interneurons and agonists, J. Neurosci., 6, 3290, 10.1523/JNEUROSCI.06-11-03290.1986 · DOI · Paper page
  83. O’Donovan, 2015, Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia, Transl. Psychiatry, 5, e579, 10.1038/tp.2015.74 · DOI
  84. Otmakhova, 1999, Dopamine selectively inhibits the direct cortical pathway to the CA1 hippocampal region, J. Neurosci., 19, 1437, 10.1523/JNEUROSCI.19-04-01437.1999 · DOI · Paper page
  85. Ottersen, 1996, Ischemic disruption of glutamate homeostasis in brain: quantitative immunocytochemical analyses, J. Chem. Neuroanat., 12, 1, 10.1016/s0891-0618(96)00178-0 · DOI
  86. Pajarillo, 2018, 17beta-estradiol and tamoxifen protect mice from manganese-induced dopaminergic neurotoxicity, Neurotoxicology, 65, 280, 10.1016/j.neuro.2017.11.008 · DOI
  87. Parkin, 2020, Excitatory amino acid transporter (EAAT).1 and EAAT2 mRNA levels are altered in the prefrontal cortex of subjects with schizophrenia, J. Psychiatr. Res., 123, 151, 10.1016/j.jpsychires.2020.02.004 · DOI
  88. Parkin, 2018, Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders, World J. Psychiatry, 8, 51, 10.5498/wjp.v8.i2.51 · DOI
  89. Pei, 2010, A model of costeff syndrome reveals metabolic and protective functions of mitochondrial OPA3, Development, 137, 2587, 10.1242/dev.043745 · DOI
  90. Pozzo Miller, 1994, Spontaneous pyramidal cell death in organotypic slice cultures from rat hippocampus is prevented by glutamate receptor antagonists, Neuroscience, 63, 471, 10.1016/0306-4522(94)90544-4 · DOI
  91. Pringle, 2000, Reducing conditions produce a loss of neuroprotective efficacy of competitive but not non-competitive antagonists in a model of NMDA-mediated excitotoxicity in organotypic hippocampal slice cultures, Acta Neurochir. Suppl., 76, 79, 10.1007/978-3-7091-6346-7_16 · doi:10.1007/978-3-7091-6346-7_16
  92. Rae, 2014, A chip off the old block: the brain slice as a model for metabolic studies of brain compartmentation and neuropharmacology, 217, 10.1007/978-1-4939-1059-5_10 · doi:10.1007/978-1-4939-1059-5_10
  93. Ramnath, 1992, Neuronal injury evoked by depolarizing agents in rat cortical cultures, Neuroscience, 51, 931, 10.1016/0306-4522(92)90530-f · DOI
  94. Rimmele, 2016, GLT-1: the elusive presynaptic glutamate transporter, Neurochem. Int., 98, 19, 10.1016/j.neuint.2016.04.010 · DOI · Paper page
  95. Robinson, 2020, Glutamate transporters and mitochondria: signaling, co-compartmentalization, functional coupling and future directions, Neurochem. Res., 45, 526, 10.1007/s11064-020-02974-8 · DOI
  96. Rothman, 1986, Glutamate and the pathophysiology of hypoxic-ischemic brain damage, Ann. Neurol., 19, 105, 10.1002/ana.410190202 · DOI · Paper page
  97. Schilp, 1999, Effects of glycine antagonists in an acute in vitro electrophysiological model of ischemia, Drug Dev. Res., 46, 134, 10.1002/(SICI)1098-2299(199902)46:2<134::AID-DDR6>3E3.0.CO;2-9 · doi:10.1002/(sici)1098-2299(199902)46:2<134::aid-ddr6>3e3.0.co;2-9
  98. Schmitt, 1996, Expression of the glutamate transporter GLT1 in neural cells of the rat central nervous system: non-radioactive in situ hybridization and comparative immunocytochemistry, Neuroscience, 71, 989, 10.1016/0306-4522(95)00477-7 · DOI
  99. Schousboe, 1981, Role of astroglial cells in glutamate homeostasis, Adv. Biochem. Psychopharmacol., 27, 103
  100. Schousboe, 1997, Role of astrocytes in glutamate homeostasis - Implications for excitotoxicity, Adv. Exp. Med. Biol., 429, 195, 10.1007/978-1-4757-9551-6_14 · DOI
  101. Schulz, 1994, Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation, J. Neurosci., 14, 5325, 10.1523/JNEUROSCI.14-09-05325.1994 · DOI · Paper page
  102. Schurr, 2012, Aerobic production and utilization of lactate satisfy increased energy demands upon neuronal activation in hippocampal slices and provide neuroprotection against oxidative stress, Front. Pharmacol., 2, 96, 10.3389/fphar.2011.00096 · DOI · Paper page
  103. Schurr, Synergism between diltiazem and MK-801 but not APV in protecting hippocampal slices against hypoxic damage, Brain Res., 684, 233, 10.1016/0006-8993(95)00466-4 · DOI
  104. Schurr, Protection by MK-801 against hypoxia-, excitotoxin- and depolarization-induced neuronal damage in vitro, Neurochem. Int., 26, 519, 10.1016/0197-0186(94)00148-n · DOI
  105. Stuart, 1991, Mechanisms of presynaptic inhibition studied using paired-pulse facilitation, Neurosci. Lett., 126, 179, 10.1016/0304-3940(91)90548-8 · DOI
  106. Takahashi, 1997, The role of glutamate transporters in glutamate homeostasis in the brain, J. Exp. Biol., 200, 401, 10.1242/jeb.200.2.401 · DOI · Paper page
  107. Tanaka, 1997, Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1, Science, 276, 1699, 10.1126/science.276.5319.1699 · DOI · Paper page
  108. Tani, 2014, A local glutamate-glutamine cycle sustains synaptic excitatory transmitter release, Neuron, 81, 888, 10.1016/j.neuron.2013.12.026 · DOI · Paper page
  109. Torp, 1994, Differential expression of two glial glutamate transporters in the rat brain: an in situ hybridization study, Eur. J. Neurosci., 6, 936, 10.1111/j.1460-9568.1994.tb00587.x · DOI · Paper page
  110. Torp, 1997, Differential distribution of the glutamate transporters GLT1 and rEAAC1 in rat cerebral cortex and thalamus: an in situ hybridization analysis, Anat. Embryol. (Berl)., 195, 317, 10.1007/s004290050051 · DOI
  111. Toth, 2021, Natural molecules and neuroprotection: kynurenic acid, pantethine and alpha-lipoic acid, Int. J. Mol. Sci., 22, 403, 10.3390/ijms22010403 · DOI
  112. Tzingounis, 2007, Glutamate transporters: confining runaway excitation by shaping synaptic transmission, Nat. Rev. Neurosci., 8, 935, 10.1038/nrn2274 · DOI · Paper page
  113. Urenjak, 2000, Neuroprotective potency of kynurenic acid against excitotoxicity, Neuroreport, 11, 1341, 10.1097/00001756-200004270-00038 · DOI
  114. Wakade, 2008, Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase, Endocrinology, 149, 367, 10.1210/en.2007-0899 · DOI · Paper page
  115. Whittingham, 1984, Metabolic stability of hippocampal slice preparations during prolonged incubation, J. Neurochem., 43, 689, 10.1111/j.1471-4159.1984.tb12788.x · DOI
  116. Wu, 2006, MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one). attenuated simulated ischemia/reperfusion injury in cultured rat hippocampal cells, Biol. Pharm. Bull., 29, 1613, 10.1248/bpb.29.1613 · DOI
  117. Wu, 1994, Presynaptic calcium is increased during normal synaptic transmission and paired-pulse facilitation, but not in long-term potentiation in area CA1 of hippocampus, J. Neurosci., 14, 645, 10.1523/jneurosci.14-02-00645.1994 · DOI · Paper page
  118. Zattoni, 2021, NMDA receptor and L-type calcium channel modulate prion formation, Cell Mol. Neurobiol., 41, 191, 10.1007/s10571-020-00834-1 · DOI
  119. Zhang, 2005, Behavioral and histological neuroprotection by tamoxifen after reversible focal cerebral ischemia, Exp. Neurol., 196, 41, 10.1016/j.expneurol.2005.07.002 · DOI
  120. Zhang, 2007, Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity, Exp. Neurol., 204, 819, 10.1016/j.expneurol.2007.01.015 · DOI
  121. Zhang, 2009, Tamoxifen mediated estrogen receptor activation protects against early impairment of hippocampal neuron excitability in an oxygen/glucose deprivation brain slice ischemia model, Brain Res., 1247, 196, 10.1016/j.brainres.2008.10.015 · DOI
  122. Zhou, 2019, Axon-terminals expressing EAAT2 (GLT-1; Slc1a2). are common in the forebrain and not limited to the hippocampus, Neurochem. Int., 123, 101, 10.1016/j.neuint.2018.03.006 · DOI
  123. Zhu, 2001, Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain, Genes Dev., 15, 859, 10.1101/gad.862101 · DOI · Paper page

Cited by

See all 41

Metadata

Authors
Rimmele, T. S., Li, S., Andersen, J. V., Westi, E. W., Rotenberg, A., Wang, J., Aldana, B. I., Selkoe, D. J., Aoki, C. J., Dulla, C. G., & Rosenberg, P. A.
Venue
Frontiers in Cellular Neuroscience
Published
2021-12-29
Volume
15
Pages
788262-788262
ISSN
1662-5102 (ISSN-L)
OpenAlex
W4200427066
Cited by
41
References
17
FWCI
2.26
Type
journal article
Language
en
Open access
gold
Funders
  • National Institutes of Health
  • Deutsche Forschungsgemeinschaft

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuronal Loss of the Glutamate Transporter GLT-1 Promotes Excitotoxic Injury in the Hippocampus. https://app.cochat.ai/papers/10.3389/fncel.2021.788262
The paper
Rimmele, T. S., Li, S., Andersen, J. V., Westi, E. W., Rotenberg, A., Wang, J., Aldana, B. I., Selkoe, D. J., Aoki, C. J., Dulla, C. G., & Rosenberg, P. A. (2021). Neuronal Loss of the Glutamate Transporter GLT-1 Promotes Excitotoxic Injury in the Hippocampus. Frontiers in Cellular Neuroscience. https://doi.org/10.3389/fncel.2021.788262

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.